Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10805
Title: Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
Austin Authors: Patterson, Scott J ;Angus, Peter W 
Affiliation: Victorian Liver Transplant Unit, Austin Health, Studley Road, Heidelberg, Victoria 3084, Australia
Issue Date: 1-Jun-2009
Publication information: Current Opinion in Organ Transplantation; 14(3): 225-30
Abstract: The established gold standard for prophylaxis against hepatitis B virus (HBV) recurrence post-liver transplant is combination hepatitis B immune globulin (HBIG) and lamivudine. This therapy reduces the risk of recurrence to less than 5% at 5 years; however, the cost of HBIG has led to the investigation of alternatives. This paper reviews the HBIG-sparing alternatives achieved with lamivudine and the prospects for the newer anti-HBV agents in post-liver transplant prophylaxis.When used with lamivudine as part of combination prophylaxis, low-dose intramuscular HBIG is equivalent to high-dose intravenous HBIG. There is recent evidence that in patients receiving HBIG/lamivudine, HBIG can be replaced with adefovir dipivoxil at 6-12 months post-liver transplant without precipitating recurrence. Furthermore, a recent study showed that primary prophylaxis with combination adefovir/lamivudine therapy without the use of long-term HBIG was effective and well tolerated as primary prophylaxis.Although there are few studies of potent newer anti-HBV agents such as entecavir or tenofovir being used as HBV prophylaxis, the properties of these drugs suggest that they should replace lamivudine within HBV prophylaxis regimes.
Gov't Doc #: 19373086
URI: http://ahro.austin.org.au/austinjspui/handle/1/10805
DOI: 10.1097/MOT.0b013e32832b1f32
URL: https://pubmed.ncbi.nlm.nih.gov/19373086
Type: Journal Article
Subjects: Adenine.administration & dosage.analogs & derivatives
Administration, Oral
Antiviral Agents.administration & dosage.adverse effects
Drug Administration Schedule
Drug Therapy, Combination
Graft Survival.drug effects
Guanine.administration & dosage.analogs & derivatives
Hepatitis B.prevention & control.surgery
Humans
Immunoglobulins.administration & dosage
Injections, Intramuscular
Lamivudine.administration & dosage
Liver Transplantation.adverse effects
Nucleosides.administration & dosage.adverse effects
Nucleotides.administration & dosage.adverse effects
Organophosphonates.administration & dosage
Secondary Prevention
Treatment Outcome
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.